Last update 08 May 2025

NCR3 x ROR1

Basic Info

Related Targets
NCR3ROR1

Related

1
Drugs associated with NCR3 x ROR1
HBM-7025
Target
NCR3 x ROR1
Mechanism
NCR3 inhibitors [+1]
Active Org.-
Originator Org.
Harbour BioMed (Shanghai) Co., Ltd.Harbour BioMed (Shanghai) Co., Ltd.
Active Indication-
Inactive Indication
Neoplasms
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with NCR3 x ROR1
Login to view more data
100 Translational Medicine associated with NCR3 x ROR1
Login to view more data
0 Patents (Medical) associated with NCR3 x ROR1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free